Genetic Profiling in Non-Small Cell Lung Cancer
Author Information
Author(s): Genni M Newnham, Matthew Conron, SueAnne McLachlan, Alexander Dobrovic, Hongdo Do, Jason Li, Kenneth Opeskin, Natalie Thompson, Gavin M Wright, David M Thomas
Primary Institution: St Vincent's Hospital, Melbourne, Australia
Hypothesis
The study aims to identify critical genes involved in non-small cell lung cancer (NSCLC) pathogenesis.
Conclusion
The results may help identify new predictive biomarkers and targets for novel therapies to improve outcomes for NSCLC patients.
Supporting Evidence
- Combined analyses identified specific patterns of genetic alteration associated with adenocarcinoma vs. squamous differentiation.
- Amplification of 3q was associated with mutations in TP53 in adenocarcinoma.
- A prognostic signature for disease recurrence was validated in an independent test set.
Takeaway
Researchers looked at the genes in lung cancer samples to find out which ones might help doctors treat the disease better.
Methodology
Transcriptional and genomic profiling were performed on 69 resected NSCLC specimens, correlating results with mutational analyses and clinical data.
Limitations
The study size is small, which may limit the strength of the conclusions.
Participant Demographics
{"gender":{"male":42,"female":27},"age":{"median":70,"range":"29 - 85"},"histology":{"adenocarcinoma":30,"squamous cell carcinoma":23,"large cell carcinoma":16},"smoking_status":{"never":16,"current/ex":53}}
Statistical Information
P-Value
p = 0.083
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website